Elicio Therapeutics Prepares $40 Million IPO Plan

janiecbros/E+ via Getty Images
Quick Take
Elicio Therapeutics (ELTX) has filed to raise $40 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm is a clinical stage biopharma developing immunotherapies for various…

Click here to view the original article.